This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Kahn, J. Ethnic drugs. Hastings Center Report (January/February 2005).
Taylor, A. et al. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N. Engl. J. Med. 351, 2049–2057 (2004).
Kahn, J. How a drug becomes 'ethnic': law, commerce, and the production of racial categories in medicine. Yale J. Health Policy Law Ethics 4, 1–46 (2004).
Tate, S.K. & Goldstein, D.B. Will tomorrow's medicines work for everyone? Nat. Genet. Suppl., S36–S37 (2004).
Moore, J. Hypertension treatment among blacks: should it be different? Today in Cardiology (October 2003).
Entine, J. Taboo: Why Black Athletes Dominate Sports and Why We are Afraid to Talk About It (PublicAffairs, New York, 2001).
Satel, S. I am a racially profiling doctor. New York Times Magazine (5 May 2002).
Duster, T. Enhanced: race and reification in science. Science 307, 1050–1051 (2005).
Maugh, T. Drug for blacks only stirs hope, concern. Los Angeles Times (9 November 2004).
Ahuja, A. We can treat your heart disease ... if you're black. Times of London (29 October 2004).
Editorial. Toward the first racial medicine. New York Times (13 November 2004).
Anonymous. Racial diversity in drug trials can produce breakthroughs. USA Today (14 November 2004).
Satel, S. Race and medicine can mix without prejudice: How the story of BiDil illuminates the future of medicine. Medical Progress Today (10 December 2004).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kahn, J. Misreading race and genomics after BiDil. Nat Genet 37, 655–656 (2005). https://doi.org/10.1038/ng0705-655
Issue Date:
DOI: https://doi.org/10.1038/ng0705-655
This article is cited by
-
Race-based heart drug might stall search for better markers
Nature Medicine (2005)